Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration

Background: Diabetes is associated with poorer outcomes and increased complication rates in STEMI patients undergoing percutaneous coronary intervention (PCI). Data are notably lacking in the Asia-Pacific region. We report the overall association of Diabetes with clinical characteristics and outcome...

Full description

Bibliographic Details
Main Authors: Wong, M.Y.Z., Yap, J.J.L., Chih, Hui Jun, Yan, B.P.Y., Fong, A.Y.Y., Beltrame, J.F., Wijaya, I.P., Nguyen, H.T.T., Brennan, A.L., Reid, Christopher, Yeo, K.K.
Format: Journal Article
Language:English
Published: 2023
Subjects:
Online Access:http://purl.org/au-research/grants/nhmrc/546272
http://hdl.handle.net/20.500.11937/93769
_version_ 1848765784932745216
author Wong, M.Y.Z.
Yap, J.J.L.
Chih, Hui Jun
Yan, B.P.Y.
Fong, A.Y.Y.
Beltrame, J.F.
Wijaya, I.P.
Nguyen, H.T.T.
Brennan, A.L.
Reid, Christopher
Yeo, K.K.
author_facet Wong, M.Y.Z.
Yap, J.J.L.
Chih, Hui Jun
Yan, B.P.Y.
Fong, A.Y.Y.
Beltrame, J.F.
Wijaya, I.P.
Nguyen, H.T.T.
Brennan, A.L.
Reid, Christopher
Yeo, K.K.
author_sort Wong, M.Y.Z.
building Curtin Institutional Repository
collection Online Access
description Background: Diabetes is associated with poorer outcomes and increased complication rates in STEMI patients undergoing percutaneous coronary intervention (PCI). Data are notably lacking in the Asia-Pacific region. We report the overall association of Diabetes with clinical characteristics and outcomes in STEMI patients undergoing PCI across the Asia-Pacific, with a particular focus on regional differences. Methodology: The Asia Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration consists of data from various PCI registries across Australia, Hong Kong, Singapore, Malaysia, Indonesia and Vietnam. Clinical characteristics, lesion characteristics, and outcomes were provided for STEMI patients. Key outcomes included 30-day overall mortality and major adverse cardiovascular events (MACE). Results: A total of 12,144 STEMI patients (mean(SD) age 59.3(12.3)) were included, of which 3912 (32.2%) had diabetes. Patients with diabetes were likely to have a higher baseline risk profile, poorer clinical presentation, and more complex lesion patterns (all p < 0.05). Across all regions, patients with diabetes had a higher rate of 30-day mortality and MACE (all p < 0.05). After multivariable adjustment, diabetes was significantly associated with both increased 30-day mortality (9.6%vs 5.5%, OR 1.79 [95% CI 1.40–2.30]) and MACE (13.3% vs 8.6%, R 1.73 [1.44–2.08]). The association between diabetes and 30-day MACE varied by region (pinteraction = 0.041), with the association (OR) ranging from 1.34 [1.08–1.67] in Malaysia, to 2.39 [1.66–3.45] in Singapore. Conclusions: Diabetes portends poorer clinical outcomes in STEMI patients undergoing PCI in the Asia-Pacific with regional variations noted. The development of effective preventative measures and interventional strategies targetted at this high-risk group is crucial.
first_indexed 2025-11-14T11:40:46Z
format Journal Article
id curtin-20.500.11937-93769
institution Curtin University Malaysia
institution_category Local University
language eng
last_indexed 2025-11-14T11:40:46Z
publishDate 2023
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-937692024-01-10T02:50:19Z Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration Wong, M.Y.Z. Yap, J.J.L. Chih, Hui Jun Yan, B.P.Y. Fong, A.Y.Y. Beltrame, J.F. Wijaya, I.P. Nguyen, H.T.T. Brennan, A.L. Reid, Christopher Yeo, K.K. Asia-Pacific Diabetes Percutaneous coronary intervention Regional differences STEMI Humans Middle Aged Percutaneous Coronary Intervention Risk Factors Treatment Outcome ST Elevation Myocardial Infarction Diabetes Mellitus Hong Kong Humans Diabetes Mellitus Treatment Outcome Risk Factors Middle Aged Hong Kong Percutaneous Coronary Intervention ST Elevation Myocardial Infarction Background: Diabetes is associated with poorer outcomes and increased complication rates in STEMI patients undergoing percutaneous coronary intervention (PCI). Data are notably lacking in the Asia-Pacific region. We report the overall association of Diabetes with clinical characteristics and outcomes in STEMI patients undergoing PCI across the Asia-Pacific, with a particular focus on regional differences. Methodology: The Asia Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration consists of data from various PCI registries across Australia, Hong Kong, Singapore, Malaysia, Indonesia and Vietnam. Clinical characteristics, lesion characteristics, and outcomes were provided for STEMI patients. Key outcomes included 30-day overall mortality and major adverse cardiovascular events (MACE). Results: A total of 12,144 STEMI patients (mean(SD) age 59.3(12.3)) were included, of which 3912 (32.2%) had diabetes. Patients with diabetes were likely to have a higher baseline risk profile, poorer clinical presentation, and more complex lesion patterns (all p < 0.05). Across all regions, patients with diabetes had a higher rate of 30-day mortality and MACE (all p < 0.05). After multivariable adjustment, diabetes was significantly associated with both increased 30-day mortality (9.6%vs 5.5%, OR 1.79 [95% CI 1.40–2.30]) and MACE (13.3% vs 8.6%, R 1.73 [1.44–2.08]). The association between diabetes and 30-day MACE varied by region (pinteraction = 0.041), with the association (OR) ranging from 1.34 [1.08–1.67] in Malaysia, to 2.39 [1.66–3.45] in Singapore. Conclusions: Diabetes portends poorer clinical outcomes in STEMI patients undergoing PCI in the Asia-Pacific with regional variations noted. The development of effective preventative measures and interventional strategies targetted at this high-risk group is crucial. 2023 Journal Article http://hdl.handle.net/20.500.11937/93769 10.1016/j.ijcard.2022.10.001 eng http://purl.org/au-research/grants/nhmrc/546272 http://purl.org/au-research/grants/nhmrc/1136372 restricted
spellingShingle Asia-Pacific
Diabetes
Percutaneous coronary intervention
Regional differences
STEMI
Humans
Middle Aged
Percutaneous Coronary Intervention
Risk Factors
Treatment Outcome
ST Elevation Myocardial Infarction
Diabetes Mellitus
Hong Kong
Humans
Diabetes Mellitus
Treatment Outcome
Risk Factors
Middle Aged
Hong Kong
Percutaneous Coronary Intervention
ST Elevation Myocardial Infarction
Wong, M.Y.Z.
Yap, J.J.L.
Chih, Hui Jun
Yan, B.P.Y.
Fong, A.Y.Y.
Beltrame, J.F.
Wijaya, I.P.
Nguyen, H.T.T.
Brennan, A.L.
Reid, Christopher
Yeo, K.K.
Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration
title Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration
title_full Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration
title_fullStr Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration
title_full_unstemmed Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration
title_short Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration
title_sort regional differences in percutaneous coronary intervention outcomes in stemi patients with diabetes: the asia-pacific evaluation of cardiovascular therapies (aspect) collaboration
topic Asia-Pacific
Diabetes
Percutaneous coronary intervention
Regional differences
STEMI
Humans
Middle Aged
Percutaneous Coronary Intervention
Risk Factors
Treatment Outcome
ST Elevation Myocardial Infarction
Diabetes Mellitus
Hong Kong
Humans
Diabetes Mellitus
Treatment Outcome
Risk Factors
Middle Aged
Hong Kong
Percutaneous Coronary Intervention
ST Elevation Myocardial Infarction
url http://purl.org/au-research/grants/nhmrc/546272
http://purl.org/au-research/grants/nhmrc/546272
http://hdl.handle.net/20.500.11937/93769